Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
about
Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis.A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis.Acquired hemophilia A: Updated review of evidence and treatment guidance.Untangling the complexity of blood coagulation network: use of computational modelling in pharmacology and diagnostics.A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor.Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents.
P2860
Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Feasibility of using thrombin ...... hemophilia having inhibitors.
@en
type
label
Feasibility of using thrombin ...... hemophilia having inhibitors.
@en
prefLabel
Feasibility of using thrombin ...... hemophilia having inhibitors.
@en
P2093
P2860
P356
P1476
Feasibility of using thrombin ...... hemophilia having inhibitors.
@en
P2093
Basri Bilenoglu
Can Balkan
Deniz Yilmaz Karapinar
Kaan Kavakli
Mehmet Akin
P2860
P304
P356
10.1177/1076029612438611
P577
2012-03-05T00:00:00Z